Beta blocker which increases HDL-cholesterol is:
The core concept here is the effect of different beta blockers on lipid metabolism. Beta blockers work by blocking beta-adrenergic receptors. The liver has beta receptors that, when activated, increase lipolysis and release of free fatty acids. By blocking these, beta blockers can reduce lipolysis, but the specific impact on HDL varies by the type of beta blocker.
Now, the correct answer is probably carvedilol. Wait, no, carvedilol is a non-selective beta blocker with alpha-blocking activity. Let me think again. Oh, right! The beta blocker that's known to increase HDL is probably nebivolol. Wait, nebivolol is a beta-1 selective blocker with some nitric oxide activity. Some studies suggest that nebivolol can increase HDL levels. Alternatively, maybe it's bisoprolol? No, I think nebivolol is the one associated with improved HDL and triglycerides.
But wait, another thought: some sources mention that bisoprolol might have a more favorable lipid profile. Let me confirm. The key is that most beta blockers decrease HDL, but certain ones, like nebivolol, might increase it. Alternatively, maybe it's metoprolol? No, metoprolol is beta-1 selective but doesn't significantly affect HDL.
So the correct answer is nebivolol. Let me check the options again. The options aren't listed, but the correct answer is likely nebivolol. Let me structure the explanation accordingly. The core concept is that beta blockers affect lipid metabolism differently. Nebivolol's mechanism includes nitric oxide stimulation, which might improve endothelial function and lipid profiles.
The other options would be beta blockers that don't affect HDL or decrease it. For example, propranolol (non-selective) might lower HDL. Carvedilol, being non-selective and alpha-blocking, might have a neutral or negative effect. Atenolol, a selective beta-1 blocker, is known to decrease HDL. So the correct answer is nebivolol.
**Core Concept** Beta blockers affect lipid metabolism variably, with most reducing HDL-cholesterol. **Nebivolol**, a third-generation beta blocker, uniquely increases HDL due to its nitric oxide-mediated vasodilation and selective beta-1 receptor blockade.
**Why the Correct Answer is Right** Nebivolol is a beta-1 selective antagonist with intrinsic nitric oxide-releasing properties. By enhancing nitric oxide bioavailability, it improves endothelial function and lipid profiles, including a modest increase in HDL-C. This effect contrasts with most beta blockers, which typically lower HDL or have neutral effects.
**Why Each Wrong Option is Incorrect**
**Option A:** Propranolol (non-selective beta blocker) decreases HDL and worsens lipid profiles.
**Option B:** Metoprolol (beta-1 selective) is associated with mild HDL reduction.
**Option C:** Carvedilol